|
US7078042B2
(en)
*
|
1995-09-15 |
2006-07-18 |
Uab Research Foundation |
Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor
|
|
US6245335B1
(en)
|
1996-05-01 |
2001-06-12 |
The Rockefeller University |
Choline binding proteins for anti-pneumococcal vaccines
|
|
US5928895A
(en)
*
|
1996-09-24 |
1999-07-27 |
Smithkline Beecham Corporation |
IgA Fc binding protein
|
|
AU9574598A
(en)
*
|
1997-09-18 |
1999-04-05 |
Pasteur Merieux Connaught |
Improved method of production of pneumococcal surface proteins
|
|
US6858706B2
(en)
|
1998-04-07 |
2005-02-22 |
St. Jude Children's Research Hospital |
Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
|
|
AU2004200125B2
(en)
*
|
1998-04-07 |
2006-07-27 |
Med Immune, Inc. |
Derivatives of Pneumococcal Choline Binding Proteins for Vaccines
|
|
IL138939A0
(en)
*
|
1998-04-07 |
2001-11-25 |
St Jude Childrens Res Hospital |
A polypeptide comprising the amino acid of an n-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
|
|
DE69942176D1
(de)
*
|
1998-04-07 |
2010-05-06 |
Medimmune Llc |
Choline-bindende proteine derivate aus pneumokoken als impfstoff
|
|
US20010016200A1
(en)
|
1998-04-23 |
2001-08-23 |
Briles David E. |
Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor
|
|
WO1999053940A1
(en)
*
|
1998-04-23 |
1999-10-28 |
Uab Research Foundation |
PNEUMOCOCCAL SURFACE PROTEIN C(PspC), EPITOPIC REGIONS AND STRAIN SELECTION THEREOF, AND USES THEREFOR
|
|
US6908898B1
(en)
*
|
1998-06-15 |
2005-06-21 |
Lars Holmgren |
Angiogenesis related molecules
|
|
EP1785486A3
(en)
*
|
1998-07-27 |
2007-08-08 |
Sanofi Pasteur Limited |
Streptococcus pneumoniae proteins and nucleic acid molecules
|
|
US6936252B2
(en)
|
1998-07-27 |
2005-08-30 |
Microbial Technics Limited |
Streptococcus pneumoniae proteins and nucleic acid molecules
|
|
ATE459373T1
(de)
|
1999-03-19 |
2010-03-15 |
Glaxosmithkline Biolog Sa |
Impfstoff gegen kapsulare polysaccharide von streptococcus pneumoniae
|
|
GB9918319D0
(en)
|
1999-08-03 |
1999-10-06 |
Smithkline Beecham Biolog |
Vaccine composition
|
|
BE1013344A3
(nl)
*
|
2000-03-08 |
2001-12-04 |
Organic Waste Systems Nv |
Werkwijze voor het behandelen van vast afval met een organische fr actie.
|
|
WO2001071038A1
(en)
*
|
2000-03-20 |
2001-09-27 |
The Rockefeller University |
Inhibition of penicillin resistance in s. pneumoniae
|
|
CA2410604A1
(en)
*
|
2000-06-14 |
2001-12-20 |
Cytovax Biotechnologies, Inc. |
Use of coiled-coil structural scaffold to generate structure-specific peptides
|
|
GB0022742D0
(en)
|
2000-09-15 |
2000-11-01 |
Smithkline Beecham Biolog |
Vaccine
|
|
US20060057160A1
(en)
|
2002-08-02 |
2006-03-16 |
Ralph Biemans |
Vaccine composition
|
|
CA2503946C
(en)
|
2002-11-01 |
2016-08-16 |
Glaxosmithkline Biologicals S.A. |
Drying process
|
|
US8541003B2
(en)
|
2003-06-20 |
2013-09-24 |
Protein Sciences Corporation |
Vectors expressing SARS immunogens, compositions containing such vectors or expression products thereof, methods and assays for making and using
|
|
EP1667712B1
(en)
|
2003-10-02 |
2010-07-21 |
GlaxoSmithKline Biologicals S.A. |
B. pertussis antigens and use thereof in vaccination
|
|
JP2007512006A
(ja)
*
|
2003-11-10 |
2007-05-17 |
ザ ユーエービー リサーチ ファウンデーション |
細菌輸送およびｃｎｓ侵襲を低減させるための組成物およびこの組成物を使用する方法
|
|
EP1863836B1
(en)
*
|
2005-03-18 |
2012-07-11 |
Novozymes Adenium Biotech A/S |
Polypeptides having antimicrobial activity and polynucleotides encoding same
|
|
GB0505996D0
(en)
|
2005-03-23 |
2005-04-27 |
Glaxosmithkline Biolog Sa |
Fermentation process
|
|
TWI457133B
(zh)
|
2005-12-13 |
2014-10-21 |
Glaxosmithkline Biolog Sa |
新穎組合物
|
|
GB0607088D0
(en)
|
2006-04-07 |
2006-05-17 |
Glaxosmithkline Biolog Sa |
Vaccine
|
|
KR101515078B1
(ko)
|
2005-12-22 |
2015-04-24 |
글락소스미스클라인 바이오로지칼즈 에스.에이. |
백신
|
|
MY150105A
(en)
|
2006-01-17 |
2013-11-29 |
Forsgren Arne |
A novel surface exposed haemophilus influenzae protein (protein e; pe)
|
|
ATE536370T1
(de)
*
|
2006-02-02 |
2011-12-15 |
Univ Alabama Res Found |
Nicht gespulte schutzregionen der pneumokokken- oberflächenproteine pspa und pspc
|
|
WO2008022299A1
(en)
*
|
2006-08-17 |
2008-02-21 |
The Uab Research Foundation |
Diagnosing pneumococcal pneumonia
|
|
CN101688194B
(zh)
|
2007-05-23 |
2013-09-11 |
Uab研究基金会 |
去毒的肺炎球菌神经氨酸酶及其用途
|
|
CA2690708A1
(en)
|
2007-06-26 |
2008-12-31 |
Glaxosmithkline Biologicals S.A. |
Vaccine
|
|
US8052873B1
(en)
*
|
2007-10-31 |
2011-11-08 |
Environmental Business Specialists, LLC |
Bacterial cultivation system for growth of substrate specific micro-organisms for use in industrial wastewater remediation
|
|
ES2553113T3
(es)
|
2008-04-16 |
2015-12-04 |
Glaxosmithkline Biologicals S.A. |
Vacuna
|
|
GB201003924D0
(en)
|
2010-03-09 |
2010-04-21 |
Glaxosmithkline Biolog Sa |
Immunogenic composition
|
|
CA2792687A1
(en)
|
2010-03-10 |
2011-09-15 |
Glaxosmithkline Biologicals S.A. |
Immunogenic composition
|
|
GB201015132D0
(en)
|
2010-09-10 |
2010-10-27 |
Univ Bristol |
Vaccine composition
|
|
CN103533953A
(zh)
|
2011-05-17 |
2014-01-22 |
葛兰素史密丝克莱恩生物有限公司 |
针对肺炎链球菌的疫苗
|
|
CN102516373B
(zh)
*
|
2011-12-30 |
2013-07-31 |
天津康希诺生物技术有限公司 |
去除人同源性的肺炎链球菌表面蛋白a、纯化方法及用途
|
|
CN104812405A
(zh)
|
2012-09-19 |
2015-07-29 |
国立大学法人大阪大学 |
含有肺炎球菌表面蛋白a的肺炎球菌疫苗
|
|
GB201318170D0
(en)
*
|
2013-10-14 |
2013-11-27 |
Univ Edinburgh |
Proteins with Diagnostic and Therapeutic Uses
|
|
EP3077410B1
(en)
*
|
2013-12-03 |
2021-02-03 |
Virometix AG |
Proline-rich peptides protective against s. pneumoniae
|
|
GB201518684D0
(en)
|
2015-10-21 |
2015-12-02 |
Glaxosmithkline Biolog Sa |
Vaccine
|
|
CN108884134A
(zh)
|
2015-12-10 |
2018-11-23 |
加拿大全国研究委员会 |
脂化肺炎链球菌抗原组合物、制备方法和用途
|
|
WO2017130222A1
(en)
|
2016-01-27 |
2017-08-03 |
Magellan Life Sciences Private Limited |
Process for extracellular secretion of brazzein
|
|
CN110381992A
(zh)
*
|
2016-12-03 |
2019-10-25 |
Uab研究基金会 |
组合了肺炎球菌表面蛋白A的选择的α螺旋结构域和脯氨酸富集结构域的肺炎球菌疫苗
|
|
GB201711635D0
(en)
|
2017-07-19 |
2017-08-30 |
Glaxosmithkline Biologicals Sa |
Immunogenic composition
|
|
CN121487960A
(zh)
*
|
2023-04-30 |
2026-02-06 |
布坦坦研究院 |
重组蛋白、表达盒、免疫原性组合物及其用途
|